Instructional Courses

Buy courses during registration or login to your account
if you have already registered

  • Sunday 10 September
    08:00-09:30

  • IC 30
  • The Importance of Fibrosis in Neovascular AMD: Can We Identify and Treat it?

    Richard Gale UK


    • 08.00
    • T. Aslam UK
      Why is Fibrosis an unmet need in nvAMD?

    • 08.15

    • U. Chakravarthy UK
      Dissecting the risk factors for fibrosis in neovascular AMD in the anti-VEGF era

    • 08.30

    • K. Balaskas UK
      Can OCT-Angiography be useful in imaging fibrosis?

    • 08.45

    • P. Keane UK
      Challenges in interpretation of OCT-A images of highly reflective material

    • 09.00

    • N. Beare UK
      Results of clinical trials that reduce fibrosis

    • 09.15

    • R. Gale UK
      Further questions and Summary

    • 09.30

    • End of course

  • IC 31
  • Demystifying Extreme Retinal Surgery

    Cyrus Shroff INDIA


    • 08.00
    • D. Grewal USA
      Retinal detachments with advanced proliferative vitreoretinopathy

    • 08.10

    • Discussion

    • 08.15

    • C. Shroff INDIA
      Morbid proliferative diabetic retinopathy

    • 08.25

    • Discussion

    • 08.30

    • D. Shroff INDIA
      Management of recurrent retinal detachment

    • 08.40

    • Discussion

    • 08.45

    • D. Ratra INDIA
      Extreme trauma

    • 08.55

    • Discussion

    • 09.00

    • A. Kothari INDIA
      Fulminant Endophthalmitis

    • 09.10

    • Discussion

    • 09.30

    • End of course



  • IC 32
  • Achieving Optimal Cataract Surgery Outcomes in Eyes with Retinal Disease or Uveitis

    Zaid Shalchi UK


    • 08.00
    • Z. Shalchi UK
      Introduction and basic concepts

    • 08.05

    • R. Hamilton UK
      Cataract surgery in eyes with exudative and non-exudative AMD

    • 08.20

    • Z. Shalchi UK
      Cataract surgery in the diabetic eye

    • 08.35

    • E. Hughes UK
      Managing the uveitic cataract

    • 08.50

    • A. Tufail UK
      Managing post-operative cystoid macular oedema

    • 09.05

    • A. Grabowska UK
      Case presentation and surgical pearls

    • 09.15

    • Panel Discussion and questions

    • 09.20

    • End of Session


  • Sunday 10 September
    10:00-11:30

  • IC 33
  • Bringing Intraoperative Imaging and Visualization to Clinical Reality Novel Routine Applications and Techniques

    Susanne Binder AUSTRIA Lars-Olof Hattenbach GERMANY


    • 10.00
    • M. Maier GERMANY
      Achieving the maximum information – How to incorporate intraoperative real-time OCT into your surgical routine

    • 10.15

    • C. Arndt FRANCE
      Intraoperative OCT-Based decision making in vitreoretinal surgery

    • 10.30

    • L. Hattenbach GERMANY
      Expanding the scope of vitreoretinal surgery: Novel intraoperative applications of real-time OCT and 3D imaging

    • 10.45

    • R. Tadayoni FRANCE
      Long-term experience with intraoperative imaging and enhanced visualization in vitreomacular interface diseases

    • 11.00

    • C. Framme GERMANY
      Intraoperative Imaging in retinal detachment surgery

    • 11.15

    • S. Binder AUSTRIA
      Bringing intraoperative three-dimensional optical coherence tomography mapping to clinical reality

    • 11.30

    • End of course

  • IC 34
  • Subthreshold Laser Surgery-Advantages & Disadvantages of Micropulse & Other Subthreshold Laser Techniques

    Victor Chong UK Jan Keunen NETHERLANDS Jeffrey Luttrull USA Eduardo Midena ITALY


    • 10.00
    • J. Keunen THE NETHERLANDS
      Introduction: What's new in subthreshold laser surgery and what have we learned so far?
    • 10.10

    • V. Chong UNITED KINGDOM
      Basic principles of micropulse laser and differences to other subthreshold laser techniques

    • 10.25

    • E. Midena ITALY
      Subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation in DME

    • 10.40

    • J. Luttrull USA
      Safety of transfoveal subthreshold diode micropulse laser and important new developments

    • 11.00

    • J. Keunen THE NETHERLANDS
      Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: Evaluation of a prospective treatment protocol.

    • 11.05

    • J. Keunen, J. Luttrull, E. Midena, V. Chong
      Presentation of challenging cases, followed by active discussion of the panel with the audience, including a case with a serious complication

    • 11.30

    • End of course

  • IC 35
  • DR Screening Programmes Around the World: Success Factors

    Andrzej Grzybowski POLAND Einar Stefansson ICELAND


    • 10.00
    • A. Grzybowski POLAND
      Epidemiology of diabetic retinopathy

    • 10.10

    • E. Stefansson ICELAND
      More efficient diabetic eye screening to meet global epidemic

    • 10.20

    • P. Scanlon UK
      Diabetic retinopathy screening programmes in UK


    • 10.30

    • P. Silva USA
      Diabetic retinopathy screening programmes in the US

    • 10.40

    • R. Kim INDIA
      Diabetic retinopathy screening programmes in India

    • 10.50

    • L. Lu CHINA
      Diabetic retinopathy screening programmes in Shanghai

    • 11.00

    • R. Kawasaki JAPAN
      Diabetic retinopathy screening programmes in Japan

    • 11.10

    • Discussion

    • 11.30

    • End of course

  • IC 36
  • OCT-Angiography in Clinical Practice from the OCT-Angiography Network Study Group: Real-World Experience & Challenges

    Konstantinos Balaskas UK


    • 10.00
    • R. Gale UK
      Artifacts and comparison between different OCT-Angiography devices

    • 10.15

    • J. Talks UK
      Experience from detecting choroidal neovascularisation with OCT-Angiography

    • 10.30

    • N. Beare UK
      Benefits and restrictions of OCT-Angiography in diabetic macular edema

    • 10.45

    • F. Ghanchi UK
      OCT-Angiography in central serous chorioretinopathy

    • 11.00

    • K. Balaskas UK
      OCT-Angiography to assess response to treatment with anti-VEGF in macular disease

    • 11.15

    • S. Sivaprasad UK
      OCT-Angiography in retinal vein occlusions

    • 11.30

    • End of course

  • Sunday 10 September
    12:00-13:30

  • IC 37
  • Optimizing Injection clinics; Focus on Biomarkers for Retreatment Decisions & Exit Strategies

    Martin Zinkernagel SWITZERLAND


    • 12.00
    • M. Zinkernagel SWITZERLAND
      Introduction

    • 12.05

    • S. Wolf SWITZERLAND
      How to use biomarkers for treatment decisions in exudative AMD; From OCT to genomics

    • 12.17

    • N. Feltgen GERMANY
      Biomarkers in the treatment of retinal vein occlusions - Imaging biomarkers to optimize patient outcomes

    • 12.29

    • P. Lanzetta ITALY
      Biomarkers in treatment decision for diabetic macular edema

    • 12.41

    • G. Turner UK
      Retreatment decisions and termination of therapy by nonconsultant staff; the retina specialist as manager?

    • 12.53

    • J. Folke Kiilgaard DENMARK
      Assessing biomarkers for retreatment decisions from afar – injection clinics in remote areas

    • 13.05

    • M. Zinkernagel SWITZERLAND
      What is the key for exit in anti-VEGF treatment?

    • 13.17

    • Discussion

    • 13.30

    • End of course


  • IC 38
  • Submacular Haemorrhages in AMD: a Practical Guide to Management

    David Yorston UK


    • 12.00
    • G. McGowan UK
      Epidemiology, mechanisms of visual loss, risk factors and classification

    • 12.13

    • Z. Koshy UK
      Treatment with anti-VEGFs alone

    • 12.26

    • J. van Meurs NETHERLANDS
      Displacement of haemorrhage with expansile gas and intravitreal TPA and anti-VEGF

    • 12.39

    • F. Treumer GERMANY
      Displacement of haemorrhage with vitrectomy and subretinal TPA/anti-VEGF

    • 12.52

    • D. Yorston UK
      Choosing the best option

    • 13.05

    • M. Veckeneer BELGIUM
      Too big to displace? What else can be tried

    • 13.18

    • Discussion

    • 13.30

    • End of course

  • IC 39
  • Vitreoretinal Surgical Rounds

    Dilraj Grewal USA


    • 12.00
    • D. Grewal USA & T. Mahmoud USA
      Introduction

    • 12.02

    • D. Grewal USA
      Surgical Video and Discussion

    • 12.12

    • T. Mahmoud USA
      Surgical Video and Discussion

    • 12.22

    • R. Avci TURKEY
      Surgical Video and Discussion

    • 12.32

    • S. Sheta EGYPT
      Surgical Video and Discussion

    • 12.42

    • C. Mateo SPAIN
      Surgical Video and Discussion

    • 12.52

    • A. Laidlaw UK
      Surgical Video and Discussion

    • 13.02

    • R. Tadayoni FRANCE
      Surgical Video and Discussion

    • 13.12

    • L. Vajzovic USA
      Surgical Video and Discussion

    • 13.22

    • D. Grewal USA & T. Mahmoud USA
      Conclusion

    • 13.30

    • End of course


  • IC 40
  • Managing Diabetic Macular Edema: Pearls & Pitfalls

    Antonia Joussen GERMANY Eduardo Midena ITALY


    • 12.00
    • A. Joussen GERMANY
      The pathogenesis of DME: The paradigm for a new treatment approach

    • 12.13

    • T. Peto UK
      The screening of DME around: Present and future perspectives

    • 12.26

    • E. Pilotto ITALY
      Multimodal retinal imaging in DME: Is it essential?

    • 12.39

    • N. Lois UK
      Laser treatment for diabetic macular edema: Revisited

    • 12.52

    • E. Midena ITALY
      DME treatment: From RCT studies to daily practice

    • 13.05

    • S. Sivaprasad UK
      Intriguing DME cases

    • 13.18

    • Discussion

    • 13.30

    • End of course


  • Sunday 10 September
    12:00-13:00

  • IC 41
  • Proliferative Vitreoretinopathy, Surgical Management & Improved Techniques

    Jose García-Arumí SPAIN


    • 12.00
    • B. Corcostegui SPAIN
      Risk factors in proliferative vitreoretinopathy

    • 12.15

    • E. El-Rayes EGYPT
      PVR in paediatric retinal detachment: Management of different scenarios

    • 12.30

    • T. Wolfensberger SWITZERLAND
      Retinotomy-retinectomy in PVR. When and how

    • 12.45

    • J. García-Arumí SPAIN
      Membrane peeling: Staining and PFCL. Viscodissection in closed funnel

    • 13.00

    • S. Rizzo ITALY
      Endotamponades in PVR

    • 13.15

    • Discussion

    • 13.30

    • End of course

EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy